Items where authors include "Rafia, R."

Article

Rafia, R., Martyn-St James, M., Harnan, S. et al. (3 more authors) (2022) A cost-effectiveness analysis of remdesivir for the treatment of hospitalised patients with COVID-19 in England and Wales. Value in Health, 25 (5). pp. 761-769. ISSN 1098-3015

Holmes, G.R. orcid.org/0000-0002-8861-9638, Ward, S.E., Brennan, A. orcid.org/0000-0002-1025-312X et al. (27 more authors) (2021) Cost-effectiveness modeling of surgery plus adjuvant endocrine therapy versus primary endocrine therapy alone in UK women aged 70 and over with early breast cancer. Value in Health, 24 (6). pp. 770-779. ISSN 1098-3015

Harnan, S. orcid.org/0000-0002-9318-9206, Tappenden, P. orcid.org/0000-0001-6612-2332, Cooper, K. orcid.org/0000-0002-7702-8103 et al. (7 more authors) (2019) Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis. Health Technology Assessment, 23 (30). ISSN 1366-5278

Davis, S. orcid.org/0000-0002-6609-4287, Rafia, R. orcid.org/0000-0002-6914-1990, Carroll, C. orcid.org/0000-0002-6361-6182 et al. (2 more authors) (2018) Pirfenidone for Treating Idiopathic Pulmonary Fibrosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics.

Rafia, R. orcid.org/0000-0002-6914-1990, Pandor, A. orcid.org/0000-0003-2552-5260, Davis, S. orcid.org/0000-0002-6609-4287 et al. (5 more authors) (2018) Obinutuzumab with Bendamustine for Treating Follicular Lymphoma Refractory to Rituximab: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 36 (10). pp. 1143-1151. ISSN 1170-7690

Scope, A. orcid.org/0000-0003-1604-1758, Essat, M., Pandor, A. et al. (5 more authors) (2017) Gene expression profiling and expanded immunohistochemistry tests to guide selection of chemotherapy regimens in breast cancer management: a systematic review. International Journal of Technology Assessment in Health Care, 33 (1). pp. 32-45. ISSN 0266-4623

Carroll, C. orcid.org/0000-0002-6361-6182, Tappenden, P. orcid.org/0000-0001-6612-2332, Rafia, R. orcid.org/0000-0002-6914-1990 et al. (6 more authors) (2017) Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 35 (5). pp. 537-547. ISSN 1170-7690

Kearns, B. orcid.org/0000-0001-7730-668X, Rafia, R., Leaviss, J. et al. (4 more authors) (2017) The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation. BMC Health Serv Res, 17 (1). p. 78.

Rafia, R. orcid.org/0000-0002-6914-1990, Dodd, P.J., Brennan, A. et al. (9 more authors) (2016) An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence. Addiction, 111 (9). pp. 1616-1627. ISSN 0965-2140

Rafia, R. orcid.org/0000-0002-6914-1990, Scope, A. orcid.org/0000-0003-1604-1758, Harnan, S. orcid.org/0000-0002-9318-9206 et al. (3 more authors) (2016) Vedolizumab for Treating Moderately to Severely Active Crohn’s Disease After Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. ISSN 1170-7690

Stevenson, M. orcid.org/0000-0002-3099-9877, Pandor, A., Martyn-St James, M. orcid.org/0000-0002-4679-7831 et al. (8 more authors) (2016) Sepsis: the LightCycler SeptiFast Test MGRADE®, SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi - a systematic review and economic evaluation. Health Technology Assessment, 20 (46). pp. 1-246. ISSN 1366-5278

Brennan, A., Meier, P., Purshouse, R. et al. (5 more authors) (2015) The Sheffield Alcohol Policy Model - A Mathematical Description. Health Economics, 24 (10). 1368 - 1388. ISSN 1057-9230

Brennan, A., Meier, P., Purshouse, R. orcid.org/0000-0001-5880-1925 et al. (3 more authors) (2013) Developing policy analytics for public health strategy and decisions-the Sheffield alcohol policy model framework. Annals of Operations Research, 236 (1). pp. 149-176. ISSN 0254-5330

Ward, S., Scope, A., Rafia, R. et al. (4 more authors) (2013) Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis. Health Technology Assessment, 17 (44). ISSN 1366-5278

Brennan, A., Meier, P., Purshouse, R. et al. (3 more authors) (2012) Health Economic Assessment of Public Health Strategies for Alcohol Harm Reduction: The Sheffield Alcohol Policy Model Framework. HEDS Discussion Paper, 12/03. (Unpublished)

Proceedings Paper

Metry, A. orcid.org/0000-0001-7412-6093, Rafia, R. and Wailoo, A. orcid.org/0000-0002-9324-1617 (2022) EE315 Economic evaluation of neutralising monoclonal antibodies for the treatment of COVID-19 positive people in the community. In: Value in Health. ISPOR 2022: The Future of HEOR in Patient-Driven Digital Healthcare Systems, 15-18 May 2022, Washington, DC, USA. Elsevier BV , S395-S396.